Inhibikase Therapeutics IKT
NASDAQ IKT
$1.59 -0.04 (-2.45%)
At close: Oct 23, 2026 · 4:00 PM EDT

Inhibikase Therapeutics (IKT) Purchase of Investments (2022 - 2026)

Updated

Analysis

Inhibikase Therapeutics (IKT) Purchase of Investments (2022 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Purchased (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 307.00 Mn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 919.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 834.00 Mn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 148.00 Mn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 46.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 42.00 Mn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.54 Bn
10 Inhibikase Therapeutics 277.57 Mn -307.91 Mn - 55.03 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 55.03 Mn
Mar 31, 2026 90.58 Mn
Dec 31, 2025 98,847.00
Sep 30, 2025 39.00 Mn
Dec 31, 2024 50.11 Mn
Sep 30, 2024 1.13 Mn
Jun 30, 2024 776,974.00
Mar 31, 2024 8.43 Mn
Dec 31, 2023 8.80 Mn
Sep 30, 2023 1.95 Mn
Jun 30, 2023 -2.93 Mn
Mar 31, 2023 21.61 Mn
Sep 30, 2022 20.73 Mn
API Access

Inhibikase Therapeutics Purchase of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=purchase-of-investments&ticker=IKT&period=max&api_key=YOUR_API_KEY